Verve Therapeutics
Price & Volume
Stats
See more52W Range | $2.86-$11.40 |
Market Cap | $994M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $59.6M |
Revenue Growth (YoY) | 479% |
Gross Profit (12 Mos) | -$150.8M |
Diluted EPS | -$2.11 |
News
See moreYahoo Finance • 10 days ago
Lilly reports second-quarter 2025 financial results and raises guidance
Yahoo Finance • 15 days ago
Verve Therapeutics Inc (NASDAQ:VERV): A High-Growth Momentum Stock Aligned with Minervini’s Trend Model
Yahoo Finance • 24 days ago
Lilly and Verve announce expiration of Verve tender offer
Yahoo Finance • 25 days ago
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
About
CEO | Dr. Sekar Kathiresan M.D. |
CFO | Ms. Allison Dorval CPA |
Address | 201 Brookline Avenue, Boston, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 274 |
